Riskpilot← Back to searchSign inGet full accessLUSTER APOTEK AS
ASActiveOrg 998478383Pyramiden, 6868 GaupneRetail sale of pharmaceutical products · NACE 4773Est. 20128 employees
Revenue 2024
NOK 28M
+9% vs 2023
EBITDA margin
1.3%
-73% vs 2023
Equity ratio
5.0%
Financial strength
Net profit 2024
NOK 201K
-79% vs 2023
| Revenue | NOK 28M | +9% |
| EBITDA | NOK 361K | -73% |
| Net profit | NOK 201K | -79% |
| Total assets | NOK 6,2M | -13% |
| Equity | NOK 311K | +6% |
| Employees | 8 | — |
Legal name
LUSTER APOTEK AS
Org number
998478383
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
11. juni 2012
Share capital
NOK 150 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Sal av apotekvarer og det som naturleg høyrer til.
Address
Pyramiden, 6868 Gaupne
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 21 008 | 21 986 | 23 255 | 25 627 | 27 965 |
| Staff expenses | −3 141 | −3 223 | −3 744 | −3 907 | −5 260 |
| EBITDA | 1 257 | 1 130 | 749 | 1 351 | 361 |
| Depreciation & amort. | −109 | −109 | −116 | −109 | −113 |
| EBIT | 1 148 | 1 021 | 633 | 1 242 | 249 |
| Net financials | 2 | 4 | 13 | 4 | 9 |
| Profit before tax | 1 150 | 1 025 | 646 | 1 246 | 258 |
| Tax | 253 | 225 | 143 | 275 | 57 |
| Net profit | 897 | 799 | 503 | 972 | 201 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 979 | 5 873 | 6 538 | 7 211 | 6 247 |
| Equity | 375 | 320 | 323 | 294 | 311 |
| Long-term debt | 201 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 403 | 5 553 | 6 215 | 6 917 | 5 936 |
| Total debt | 4 604 | 5 553 | 6 215 | 6 917 | 5 936 |
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
20202024
Equity ratio
5.0%
This company
38.2%
Market median
-87% vs market
20202024
Return on equity
64.4%
This company
18.4%
Market median
+250% vs market
20202024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20202024
Asset turnover
4.48×
This company
1.12×
Market median
+300% vs market
20202024
Debt / equity
19.07×
This company
0.62×
Market median
-2976% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SE Chief Executive Officer | Chief Executive Officer | 2023 |
SE Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
JP Chief Executive Officer | Chief Executive Officer | 2020 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Uthus Holding As
LUSTER APOTEK AS Board members of LUSTER APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stine Eidslott Fossøy | Chief Executive Officer | 0 companies |
| Jovana Petkovic | Chief Executive Officer | 0 companies |
| Stine Eidslott | Chief Executive Officer | 0 companies |
| Ole Jonny Uthus | Chairman | 0 companies |
| Morten Hole Uthus | Board of Directors | 0 companies |
| Ove Ellingsen | Chairman | 0 companies |